Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 2, 2013, Pages 329-335

  Davenport, Matthew S ^a   Heye, Tobias ^b   Dale, Brian M ^b   Horvath, Jeffrey J ^b   Breault, Steven R ^b   Feuerlein, Sebastian ^c   Bashir, Mustafa R ^b   Boll, Daniel T ^b   Merkle, Elmar M ^d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

DCE MRI; perfusion; reproducibility

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; EXTRACELLULAR EXTRAVASCULAR SPACE VOLUME; FEMALE; FLUX RATE CONSTANT; HUMAN; INITIAL AREA UNDER THE GADOLINIUM TIME CURVE; INTERRATER REPRODUCIBILITY; INTRARATER REPRODUCIBILITY; KINETICS; MEASUREMENT ERROR; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; REPEAT PROCEDURE; REPRODUCIBILITY; RETROSPECTIVE STUDY; TIME RESOLVED ANGIOGRAPHY WITH INTERLEAVED STOCHASTIC TRAJECTORIES; UTERUS MYOMA; VOLUME TRANSFER CONSTANT;

DCE-MRI; PERFUSION; REPRODUCIBILITY;

ADULT; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEIOMYOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MEGLUMINE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UTERINE NEOPLASMS;

EID: 84882565225     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23974     Document Type: Article

References (20)

1. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Mag Reson Imaging 1999; 10: 223-232. (Pubitemid 29463104)
2. Koh TS, Thng CH, Hartono S, et al. A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy. NMR Biomed 2011; 24: 1169-1180.
3. Knopp MV, Giesel FL, Marcos H, et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001; 12: 301-308. (Pubitemid 33031399)
4. Walker-Samuel S, Leach MO, Collins DJ,. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC and quantitative pharmacokinetic analysis. Phys Med Biol 2006; 51: 3593-3602. (Pubitemid 44026420)
5. Padhani AR,. MRI for assessing antivascular cancer treatments. Br J Radiol 2003; 76: S60-S80. (Pubitemid 39530317)
6. Casneuf VF, Delrue L, Van Damme N, et al. Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent. 2011; 175: 10-20.
7. Preda A, van Vliet M, Krestin GP, et al. Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition. Invest Radiol 2006; 41: 325-331. (Pubitemid 44406194)
8. Turetschek K, Preda A, Floyd E, et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med Mol Imaging 2003; 30: 448-455. (Pubitemid 36692873)
9. Turkbey B, Thomasson D, Pang Y, et al. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 2010; 16: 186-192.
10. Homer J, Beevers MS,. Driven-equilibrium single-pulse observation of T1 relaxation. A reevaluation of a rapid "new" method for determining NMR spin-lattice relaxation-times. J Magn Reson 1985; 63: 287-297.
11. Tofts PS, Kermode AG,. 1991 Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17: 357-367.
12. Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006; 56: 993-1000. (Pubitemid 44691341)
13. Padhani AR, Hayes C, Landau S, Leach MO,. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 2002; 15: 143-153. (Pubitemid 34213404)
14. Galbraith SM, Lodge MA, Taylor NJ, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002; 15: 132-142. (Pubitemid 34213403)
15. Ng CS, Raunig DL, Jackson EF, et al. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol 2010; 194: W134-W140.
16. Lankester KJ, Taylor NJ, Stirling JJ, et al. Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI. Br J Cancer 2005; 93: 979-985. (Pubitemid 41548390)
17. Jackson A, Jayson GC, Li KL, et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 2003; 76: 153-162. (Pubitemid 36553239)
18. Ashton E, Raunig D, Ng C, et al. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging 2008; 28: 791-796.
19. Ferl GZ, Xu L, Friesenhahn M, et al. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. Magn Reson Med 2010; 63: 1366-1375.
20. Roberts C, Issa B, Stone A, et al. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006; 23: 554-563.